PD
RGNX icon

Point72 (DIFC)’s Regenxbio RGNX Stock Holding History

Point72 (DIFC)’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-11,224
Closed -$80.3K – 2007
2025
Q1 		$80.3K Sell
11,224
-2,007
-15% -$14.9K ﹤0.01% 1111
2024
Q4 		$102K Buy
+13,231
New +$124K ﹤0.01% 1000
2024
Q3 		– Sell
-3,806
Closed -$44.5K – 1762
2024
Q2 		$44.5K Sell
3,806
-14,398
-79% -$224K ﹤0.01% 1112
2024
Q1 		$384K Buy
+18,204
New +$324K 0.01% 815

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Point72 (DIFC)'s RGNX Position: Q2 2025 in Review

Point72 (DIFC) sold out of Regenxbio (RGNX) in Q2 2025, closing a stake of 11,224 shares — an estimated $80.3K sold.

Point72 (DIFC) first reported a position in RGNX in Q1 2024 and held it in 4 quarters. The position peaked at $384K in Q1 2024. 159 funds tracked by Wall St. Rank hold RGNX as of Q2 2025.

  • Point72 (DIFC) reported no remaining Regenxbio position as of Q2 2025 after selling out during the quarter.
  • Point72 (DIFC) sold 11,224 Regenxbio shares in Q2 2025, an estimated $80.3K.
  • Point72 (DIFC) first reported a position in Regenxbio in Q1 2024 and held it in 4 quarters.
  • Point72 (DIFC)'s Regenxbio position peaked at $384K in Q1 2024.
  • 159 funds tracked by Wall St. Rank held Regenxbio as of Q2 2025.

Based on Point72 (DIFC)'s 13F filing for Q2 2025, filed 14 Aug 2025.